Table III.
Univariate analysis of overall survival for patients with hepatocellular carcinoma.
| Overall survival | |||
|---|---|---|---|
| Variables | Median survival days (n) | Survival (%) | Log-rank |
| Sex | 0.904 | ||
| Female | 895 | 86 | |
| Male | 1,034 | 85.2 | |
| Recurrence | 0.099 | ||
| Negative | 935 | 83.6 | |
| Positive | 634 | 100 | |
| Differentiation | 0.175 | ||
| Well | 860 | 100 | |
| Moderate | 918 | 86.6 | |
| Poor | 832 | 81.6 | |
| Clinical stage | 0.003 | ||
| Stage I, II | 928 | 87.8 | |
| Stage III, IV | 642 | 66.7 | |
| Hepatitis B | 0.967 | ||
| Negative | 919 | 85.7 | |
| Positive | 909 | 85.1 | |
| Hepatitis C | 0.567 | ||
| Negative | 915 | 84.6 | |
| Positive | 895 | 87.1 | |
| Epithelial cell adhesion molecule | 0.043 | ||
| Low | 976 | 90.3 | |
| High | 832 | 80.4 | |